Overview
Our extensive Hatch-Waxman litigation practice and successful practice in post-grant PTO proceedings, combined with our deep technical expertise in biotechnology, uniquely positions us to develop and implement effective IP strategies for biosimilars. This industry-specific expertise is backed by one of the largest and most experienced biotechnology groups in IP law, with more than 75 attorneys and scientists representing clients in all stages of their business and technology development, as well a talented litigation group adept in all aspects of biotechnology IP law.
Biosimilars Pathway Bench Strength:
- Up-to-date knowledge of biosimilars legislation
- IP litigators with numerous trial and appellate successes
- Extensive Hatch-Waxman litigation experience
- Successful Post-Grant PTO practice on behalf of patent owners and petitioners
- More than 20 attorneys with PhD’s in the life sciences
- Extensive experience in biologics patent prosecution
- Licensing and other transactional experience related to biologics
Latest Updates and News
Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences
In the ongoing case of Carefirst of Maryland Inc. v. Johnson & Johnson[1], the plaintiffs successfully overcame a motion to dismiss. At the heart of the case is J&J’s legal...
District Court Finds Mylan (Viatris) Infringes Regeneron’s Eylea Patent
On December 27, 2023, Judge Thomas S. Kleeh of the United States District Court for the Northern District of West Virginia issued an order finding that Mylan (Viatris) infringed claims 4, 7, 9, 11, and 14-17 of Regeneron’s U.S. Patent No. 11,084,865 (“the ’865 patent”) after a nine-day bench trial held in June 2023.
In IP & Tech Law Journal, Andrea Cheek and Ari Feinstein Discuss Patent Venues
Knobbe Martens partner Andrea Cheek and associate Ari Feinstein authored “Patent Venue, and How It Works in Abbreviated New Drug Application Litigation,” published in Intellectual Property & Technology Law Journal....
LMG Recognizes Knobbe Martens as Leading Life Sciences Firm
IRVINE, CALIF., September 21, 2023 – Knobbe Martens is pleased to announce that Legal Media Group (LMG) has again recognized the firm as having one of the top life sciences intellectual...
Knobbe Martens Shortlisted for “Firm of the Year,” Seven Other Categories, for Euromoney LMG Life Sciences Awards
IRVINE, CALIF., July 26, 2023 – Knobbe Martens is pleased to share that the firm and five of its partners are shortlisted in eight categories for the 2023 Euromoney Legal Media Group “LMG...
Knobbe Martens Attorneys Recognized by Washington D.C. Super Lawyers
Congratulations to partner William R. Zimmerman and associate Justin Culbertson for being included in Super Lawyers’ 2023 Washington D.C. “Super Lawyers” and “Rising Stars” lists. Mr. Zimmerman serves as managing...
